Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.13 and traded as high as $0.20. Enzon Pharmaceuticals shares last traded at $0.19, with a volume of 683,174 shares changing hands.
Enzon Pharmaceuticals Stock Performance
The firm has a market capitalization of $13.95 million, a PE ratio of 18.81 and a beta of 0.49. The stock has a fifty day moving average price of $0.10 and a 200-day moving average price of $0.13.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
See Also
- Five stocks we like better than Enzon Pharmaceuticals
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What Are Dividends? Buy the Best Dividend Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
